U.S. Treatment-resistant Depression Treatment Market Size, Share & COVID-19 Impact Analysis, By Drug Type (N-Methyl-D-aspartate (NMDA)), Antidepressants, Antipsychotics, and Others), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and Country Forecast, 2023-2030

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI108772

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2019-2030
Base Year	2022
Estimated Year	2023
Forecast Period	2023-2030
Historical Period	2019-2021
Growth Rate	CAGR of 9.2% from 2023 to 2030
Unit	Value (USD Million)
Segmentation	By Drug Type N-methyl-D-aspartate (NMDA) Antidepressants Antipsychotics Others
Segmentation	By Distribution Channel Hospital Pharmacies Drug Stores & Retail Pharmacies Online Pharmacies